Related Experiment Video
Updated: Mar 31, 2026
03:49
Author Spotlight: Optimizing EAS with Long Electrodes for Enhanced Cochlear Coverage and Hearing Preservation
Published on: October 11, 2024
1.3K
Corticosteroids: Triamcinolone, Dexamethasone and Fluocinolone
Developments in Ophthalmology
|October 27, 2015
Summary
Intraocular steroids effectively treat retinal diseases like diabetic macular edema. New drug delivery methods enhance corticosteroid therapy, improving efficacy and managing side effects.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Pharmacology
Background:
- Corticosteroids are widely used for retinal conditions such as diabetic retinopathy, venous occlusive disease, and ocular inflammation.
- Intraocular steroids like dexamethasone, triamcinolone, and fluocinolone have been utilized.
- Emerging drug delivery systems for corticosteroids represent advancements in treatment.
Purpose of the Study:
- To review the pharmacology of intraocular steroids.
- To evaluate the efficacy of steroid treatment in various retinal diseases.
- To discuss the adverse effects associated with intraocular steroid use.
Main Methods:
- Review of existing literature on intraocular steroid pharmacology.
- Analysis of clinical studies on steroid efficacy for retinal conditions.
- Compilation of data on adverse events from steroid administration.
Main Results:
- Steroids demonstrate significant efficacy in treating diabetic macular edema, venous occlusive disease, and ocular inflammation.
- New drug delivery methods are enhancing the therapeutic potential of corticosteroids.
- Understanding pharmacology, efficacy, and adverse effects is crucial for optimal patient outcomes.
Conclusions:
- Intraocular steroids remain a cornerstone in managing several retinal diseases.
- Advancements in drug delivery are improving corticosteroid treatment protocols.
- Comprehensive knowledge of steroid properties is essential for ophthalmologists.
More Related Videos
Related Concept Videos
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
2.0K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.0K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
634
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
634
01:22Drug Delivery: Miscellaneous Routes
980
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
980
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.1K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K
01:19Antiasthma Drugs: Leukotriene Modifiers
2.3K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.3K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
2.0K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.0K